Healthcare for Older Adults in Türkiye: A Call for Reform

By Melike Belenli Gümüş

November 7, 2024

A recent article published on the European Journal of Geriatrics and Gerontology, addresses the critical issues surrounding healthcare for older adults in Türkiye. The focus on healthcare problems and potential solutions emphasises that these challenges not only impact the elderly but also have broader implications for the entire healthcare system.

Population Growth and Demographic Changes

The article highlights the increasing number and proportion of older adults in Türkiye, which presents significant implications for health, social, cultural, and economic sectors. This demographic shift necessitates policy changes and regulatory adjustments to adequately address the healthcare problems faced by this population.

Geriatrics and Gerontology

The report distinguishes between geriatrics and gerontology:

Geriatrics is a subspecialty of internal medicine focused on the care, treatment, and follow-up of health problems in individuals aged 65 and over.
Gerontology is a multidisciplinary field that encompasses the physical, mental, and social aspects of aging.

Geriatric Health Challenges

Geriatrics addresses chronic diseases in older adults, with multimorbidity affecting 46% of those 65 and older in Türkiye. Conditions like hypertension, diabetes, and coronary artery disease are more prevalent in this age group (Figure 1). Moreover, osteoarthritis impacts 25% of people over 65, while osteoporosis-related fractures are common in older adults. Common cancers include breast and uterine in women, and prostate and colorectal in men. In Türkiye, lung, stomach, and lymphoma are the leading causes of cancer deaths for both genders.

Figure 1: Commonly encountered chronic diseases in older adults in Türkiye. M: Male, F: Female

Workforce and Training

There is a significant shortage of geriatricians in Türkiye. Currently, there are only about 150 geriatricians and geriatrics fellows available, whereas the need is estimated to exceed 3,000 based on scientific standards. The report highlights the need to enable geriatricians to practice in accordance with their profession, including authorization for the reimbursement of crucial drugs. Furthermore, it calls for improvements in working conditions and education for health professionals serving older adults.

Preventive Medicine and Early Diagnosis

The article stresses the importance of integrating geriatric syndromes into primary healthcare settings. It recommends training programs and follow-up materials for family physicians to conduct screenings and follow-ups. Access to healthcare services should be enhanced, especially for older adults, alongside increased health literacy and access to e-health applications. Preventing falls, particularly among frail older individuals, by creating safe home environments is also a key recommendation.

Medication Management

The report notes that older adults with type 2 diabetes and hypertension frequently receive inappropriate treatment. A study found that one in ten older adults was overtreated, while one in four required modifications to their antihyperglycemic and antihypertensive regimens. To address these healthcare problems, the “Türkiye inappropriate drug use criteria (TIME criteria)” has been established, which can be utilised on smartphones to enhance medication management.

Social Support and Quality of Life

Social support is identified as critically important for older adults. Enhancing social rights, education, and creating an effective working atmosphere for health professionals can significantly improve the quality of life for older adults. This improvement, in turn, can positively impact long-term health expenditures. Such measures are cost-effective and beneficial for the healthcare system.

Policy and Multisectoral Collaboration

A large study group, including representatives from public institutions, private sectors, ministries, universities, and professional associations, prepared the report. This collaboration highlights the urgent need for comprehensive policies. Moreover, it addresses the healthcare challenges faced by older adults in Türkiye.

In summary, the article emphasises the urgent need for policy reforms, expansion of the workforce, improved preventive care, better medication management, and enhanced social support to address the ongoing healthcare challenges faced by older adults in Türkiye. Addressing these healthcare problems is essential for ensuring a healthier future for the aging population.

Reference url

Recent Posts

oral GLP-1 medication
    

Market Leadership in Sight as Eli Lilly’s Oral GLP-1 Medication Orforglipron Succeeds in Phase 3

🌟 Ready for a breakthrough in diabetes management?

Eli Lilly’s oral GLP-1 medication, orforglipron, has completed a successful Phase 3 trial, showing remarkable efficacy in lowering A1C levels and promoting substantial weight loss. As the first oral small molecule GLP-1 receptor agonist, it offers a promising alternative to conventional injectable treatments, potentially improving patient adherence and access.

Dive into the details of this exciting development and what it means for the future of diabetes care!

#SyenzaNews #HealthTech #Innovation #Pharmaceuticals

pediatric thyroid cancer risk
    

Environmental Exposures and Pediatric Thyroid Cancer Risk: Key Findings from a California Study

🌟 Are we overlooking environmental risks in pediatric cancer?

Recent research highlights a troubling link between perinatal exposure to PM2.5 and outdoor artificial light and the increased risk of pediatric thyroid cancer. This pivotal study sheds light on how environmental factors play a critical role in childhood health, particularly among vulnerable populations.

Dive into this important discussion on how addressing these environmental exposures may reduce pediatric thyroid cancer and improve health outcomes for future generations.

#SyenzaNews #EnvironmentalHealth #HealthPolicy #Innovation

capivasertib cost-effectiveness
      

Capivasertib Cost-Effectiveness in Advanced Breast Cancer

💡What’s the strategy to bring capivasertib’s price within reach of breast cancer patients?

A recent study evaluates capivasertib, an AKT inhibitor, as a second-line treatment for advanced breast cancer, revealing that its costs significantly outweigh the added health benefits. The analysis indicates that to be cost-effective, a substantial reduction in its price is necessary.

Delve into the economic implications of this treatment and the pressing need for pricing reforms in healthcare.

#SyenzaNews #HealthEconomics #costeffectiveness #oncology

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.